Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caris Life Sciences (CAI) Treasury Shares (2024 - 2025)

Caris Life Sciences (CAI) has 2 years of Treasury Shares data on record, last reported at $16.9 million in Q4 2025.

  • For Q4 2025, Treasury Shares rose 5020.0% year-over-year to $16.9 million; the TTM value through Dec 2025 reached $16.9 million, up 5020.0%, while the annual FY2025 figure was $16.9 million, 5020.0% up from the prior year.
  • Treasury Shares reached $16.9 million in Q4 2025 per CAI's latest filing, roughly flat from $16.9 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $1.6 million in Q2 2025 and bottomed at $182500.0 in Q2 2024.